ArticleApplied microbiology and biotechnology2026
Unveiling a catalytically promiscuous feruloyl esterase from Clostridium acetobutylicum.
Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Clostridium species have garnered increasing attention for their ability to convert lignocellulosic biomass into renewable fuels and platform chemicals. Among the enzymes involved in lignin degradation, feruloyl esterases (FAEs) cleave ester bonds between ferulic acid and polysaccharide side chains, thereby facilitating the disruption of lignin-carbohydrate complexes. However, the biochemical and structural properties of Clostridium FAEs remain poorly characterized, with activity studies largely limited to model substrates rather than native lignin-derived compounds. Here, we report the functional and crystallographic characterization of a novel FAE (CaFaeA) from Clostridium acetobutylicum. CaFaeA exhibits broad catalytic activity toward a range of hydroxycinnamate esters as well as bis(2-hydroxyethyl) terephthalate (BHET), distinguishing it from typical carboxyl esterases. Furthermore, the 2.45 Å crystal structure of CaFaeA reveals a canonical α/β-hydrolase fold with a unique lid domain of three α-helices and two antiparallel β-strands partially covering the active site. Mutagenesis identified two gatekeeper residues, Y151 and E168, that regulate substrate access and catalytic performance. Remarkably, CaFaeA demonstrates exceptional tolerance to organic solvents, retaining or even enhancing activity in the presence of 25% dimethyl sulfoxide and n-hexane. With insoluble wheat arabinoxylan (I-WAX) as substrate, its unique lid architecture enabled efficient cleavage of ferulic acid-arabinose ester linkages, resulting in a release of free ferulic acid by 5.39 mg·μmol
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.